RAB38 Facilitates Energy Metabolism and Counteracts Cell Death in Glioblastoma Cells
Glioblastoma is a high-grade glial neoplasm with a patient survival of 12–18 months. Therefore, the identification of novel therapeutic targets is an urgent need. RAB38 is a GTPase protein implicated in regulating cell proliferation and survival in tumors. The role of RAB38 in glioblastoma is relati...
Main Authors: | Elena Bianchetti, Sierra J. Bates, Trang T. T. Nguyen, Markus D. Siegelin, Kevin A. Roth |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/7/1643 |
Similar Items
-
Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres
by: Deborah Fanfone, et al.
Published: (2020-10-01) -
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance
by: Jessie Pécot, et al.
Published: (2016-12-01) -
BH3 Mimetic Sensitivity of Colorectal Cancer Cell Lines in Correlation with Molecular Features Identifies Predictors of Response
by: Le Zhang, et al.
Published: (2021-04-01) -
Targeting Antiapoptotic Bcl-2 Family Members with Cell-Permeable BH3 Peptides Induces Apoptosis Signaling, Death in Head, Neck Squamous Cell Carcinoma Cells
by: Rongxiu Li, et al.
Published: (2007-10-01) -
DLBCL Cells with Acquired Resistance to Venetoclax Are Not Sensitized to BIRD-2 But Can Be Resensitized to Venetoclax through Bcl-XL Inhibition
by: Martijn Kerkhofs, et al.
Published: (2020-07-01)